Disclosures for "Disruptive Impacts of Developmental and Epileptic Encephalopathies on Patient and Family Life: a Quality-of-Life Survey"
-
Mrs. Martin has received personal compensation for serving as an employee of UCB.
-
Ms. Bailey has received personal compensation for serving as an employee of UCB, Inc.. Ms. Bailey has stock in UCB, Inc..
-
Tracy Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation.
-
Mrs. Meskis has received personal compensation in the range of $100,000-$499,999 for serving as a Executive Director with Dravet Syndrome Foundation.
-
Ms. Manzo has received personal compensation for serving as an employee of UCB Pharma. Ms. Manzo has stock in UCB Pharma.
-
Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB.
-
Ms. Wilkinson has received personal compensation for serving as an employee of UCB. Ms. Wilkinson has stock in UCB.